
pmid: 2260337
Streptomycin is an effective drug for the treatment of tuberculosis. It is currently recommended for use only by the intramuscular route. This method of drug delivery is accompanied by considerable pain which is unacceptable to many patients. With the advent of many improvements in intravenous therapy that have occurred in the past 40 years, reevaluation of the intravenous use of this drug is warranted. We describe the short-term use of intravenous streptomycin in four patients with pulmonary tuberculosis.
Adult, Male, Injections, Intravenous, Streptomycin, Humans, Middle Aged, Tuberculosis, Pulmonary
Adult, Male, Injections, Intravenous, Streptomycin, Humans, Middle Aged, Tuberculosis, Pulmonary
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 9 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
